U.S. REITS Stock News

Netflix, NasdaqGS:NFLX, has acquired InterPositive, a specialist in AI tools for filmmakers. The deal adds AI driven production capabilities that are intended to support more efficient content creation. The move aligns with Netflix’s focus on using technology in its streaming and studio operations. Netflix is trading at $92.06, with returns of 185.2% over three years and 82.7% over five years, alongside a 20.4% decline over the past year. The InterPositive acquisition comes as the company...

Why Kemper (KMPR) is on investors’ radar Kemper (KMPR) has drawn attention after recent share price moves, with a gain over the past month contrasting with weaker performance in the past 3 months and over the past year. For investors tracking insurers, this split in short term and longer term returns is prompting a closer look at Kemper’s current valuation, business mix, and recent financial results. See our latest analysis for Kemper. That recent 13.7% 1 month share price return contrasts...

DraftKings stock performance snapshot With no specific news event driving trading today, DraftKings (DKNG) sits around a last close of US$23, giving the stock a market value near US$11.6b and putting recent returns in context. Over the past year, DraftKings has delivered a total return decline of about 33%, with year to date performance showing a similar 36% decline. The stock is roughly flat over the past month and down about 16% over the past 3 months. See our latest analysis for...

In recent days, Gorilla Technology Group Inc. announced a significant expansion of its India AI infrastructure collaboration with Yotta Data Services, supporting the deployment of 20,736 additional B300 GPU cards in a multi-year project valued at about US$2.80 billion, alongside a deeper investment in real-time infrastructure intelligence firm Astrikos.AI. This combination of a very large GPU deployment tied to one of APAC’s largest NVIDIA DGX Cloud clusters and closer Astrikos.AI...

In April 2026, UnitedHealth Group reported first-quarter 2026 results showing revenue of US$111.72 billion, net income of US$6.28 billion, and diluted EPS from continuing operations of US$6.90, modestly higher than a year earlier. Alongside these results, the company raised its full-year 2026 adjusted EPS outlook and announced at least US$2 billion in share buybacks, while opposing a shareholder proposal to require an independent board chair, underscoring how it is balancing capital returns,...

CSX (CSX) released first quarter 2026 results, reporting sales of US$3,482 million and net income of US$807 million, figures that exceeded the prior year's quarter on both measures. See our latest analysis for CSX. CSX’s latest earnings release comes after a strong run in the shares, with a 30 day share price return of 9.39% and a year to date gain of 24.32%. The 1 year total shareholder return of 59.50% points to momentum that has stretched beyond the recent quarter. If these results have...

Wondering whether Travere Therapeutics at around US$44.12 is still offering value or if the easy gains are already behind it? This article unpacks what the current price really implies. The stock has shown strong share price moves, with returns of 8.9% over 7 days, 40.4% over 30 days, 11.6% year to date, 108.6% over 1 year, 162.6% over 3 years and 120.5% over 5 years. This naturally raises questions about both upside potential and risk. Recent headlines around Travere Therapeutics have...

Clearway Energy, Inc. has already converted all of its Class A common stock into Class C common stock as of May 1, 2026, with Class A trading suspended and Class C now trading on the New York Stock Exchange. This simplification of the public share structure, alongside Clearway’s simultaneous removal from numerous major Russell and S&P indexes, reshapes how index funds and active investors may gain exposure to the company. We’ll now examine how Clearway’s shift to a single Class C share...

Synchrony and Lowe's Companies have expanded their partnership with the launch of the MyLowe's Pro Rewards American Express Card. The new co branded card extends purchasing power and rewards for professional customers beyond Lowe's stores to any location where American Express is accepted. The offering targets small to medium business customers within Lowe's Pro segment, with a focus on broader rewards and financing flexibility. Lowe's Companies, NYSE:LOW, is trading at $233.33, with the...

Sable Offshore Corp. recently resumed oil transportation through key pipeline segments and expanded drilling activity after federal intervention resolved prior regulatory hurdles that had stalled production in 2025. Alongside this operational restart, the company’s executives converted large blocks of restricted stock units and sold shares mainly to cover tax obligations, underscoring substantial ongoing insider equity exposure. We’ll now examine how the resumption of oil production...

Sprouts Farmers Market is opening its first New York store as part of an accelerated nationwide rollout. The company plans more than 40 new locations in 2026, expanding its footprint beyond existing core regions. Management is rolling out targeted price adjustments, loyalty program efforts, and supply chain work to support long term growth after recent comparable sales declines. Sprouts Farmers Market, NasdaqGS:SFM, is pushing into new territory with its New York entry while ramping up...

Carnival Corporation & (NYSE:CCL) has been hit by a significant ransomware attack linked to the hacking group ShinyHunters. The incident reportedly involves more than 8,700,000 records containing sensitive personal data. Multiple class action lawsuits have been filed, alleging weak cybersecurity controls and slow notification to affected individuals. The breach is drawing fresh attention to the company’s data security practices and operational risk. Carnival Corporation & enters this data...

Event overview and recent share performance Charles River Laboratories International (CRL) has drawn investor attention after a period of weaker share performance, with the stock showing a 0.7% decline over the past day and a 2.4% decline over the past week. Those short term moves sit alongside a 5.2% decline over the past month and a 21.2% decline over the past 3 months. The shares are still up 40.0% over the past year and down 51.6% over 5 years. See our latest analysis for Charles River...

Bristol-Myers Squibb (BMY) opened 2026 with Q1 revenue of US$11.5b, basic EPS of US$1.31 and net income of US$2.7b, setting the tone for how investors will judge its recent profitability. The company has seen quarterly revenue move from US$11.2b and basic EPS of US$1.21 in Q1 2025 to US$11.5b and US$1.31 in Q1 2026. Trailing twelve month EPS reached US$3.57, giving a clearer read on earnings power over the last year. With trailing net profit margin at 15% and recent earnings growth of 34.2%...

Eastman Chemical Q1 2026 earnings: headline numbers in focus Eastman Chemical (EMN) has opened 2026 with Q1 revenue of US$2.2b and basic EPS of US$0.94, setting the stage for how investors assess the latest move in profitability. Over recent quarters the company has seen revenue move between US$2.0b and US$2.3b, with basic EPS ranging from US$0.41 to US$2.85, while trailing twelve month EPS sits at US$3.49 on revenue of US$8.6b. With the stock at US$77.53 and trailing net margin at 4.6%...

Tesla has started mass production of its long delayed Semi electric truck. The company has begun customer deliveries, moving the Semi from pilot runs to volume manufacturing in Nevada. This marks a major push beyond consumer vehicles into commercial freight and logistics. Tesla, NasdaqGS:TSLA, is extending its reach beyond passenger cars with the Semi entering full scale production. The move comes as the stock trades around $390.82, with a 36.1% return over the past year and a 129.8% return...

Why Phibro Animal Health stock is on investors’ radar Recent trading in Phibro Animal Health (PAHC) has drawn attention, with the share price at $54.89 and total return data over the past month and past 3 months prompting closer scrutiny of the business fundamentals. See our latest analysis for Phibro Animal Health. That recent one day share price return of 3.22% sits on top of a 36.71% 90 day share price return and a very large 1 year total shareholder return, which suggests momentum has...

Media spotlight puts Talen Energy (TLN) in focus Interest in Talen Energy (TLN) has picked up after Jim Cramer highlighted the stock on Mad Money, calling it a power infrastructure play with limited yield appeal, while advising a viewer to hold rather than sell. See our latest analysis for Talen Energy. Despite the recent TV spotlight, Talen Energy’s share price return over the past month is 13.44%. The year-to-date share price return is 6.19% lower, and the 1 year total shareholder return is...

In late April 2026, semiconductor manufacturer IPG Photonics was caught in a broad sector selloff as concerns over future artificial intelligence spending and rising U.S.-China technology tensions weighed on investor sentiment and raised fears of supply chain disruption. The key takeaway is that IPG Photonics’ recent volatility appears tied more to macro and industry-wide semiconductor worries than to any company-specific operational change or new information about its core laser...

Recursion Pharmaceuticals recently confirmed it will report first-quarter 2026 results and business updates on May 6, 2026, with a publicly accessible earnings call allowing questions from investors and the broader community. At the same time, the company flagged leadership changes, including Chris Gibson, Ph.D., stepping down from the Board in June 2026 while remaining an advisor, underscoring an emphasis on continuity and its AI-driven drug discovery platform. We’ll examine how the...

T. Rowe Price Group (TROW) opened 2026 with Q1 revenue of US$1.9 billion and basic EPS of US$2.23, alongside trailing twelve month revenue of US$7.4 billion and EPS of US$9.34 that sit against modest 1.9% annual revenue growth and a 27.6% net profit margin over the past year. Over recent quarters, revenue has ranged from US$1.7 billion to US$1.9 billion, while quarterly EPS has moved between roughly US$1.93 and US$2.88. This provides a consistent picture of earnings power, even as the five...

Why EnerSys Is On Investors’ Radar Today EnerSys (ENS) has caught attention after a strong run over the past year, prompting investors to reassess what the current share price might already reflect about its business mix and fundamentals. See our latest analysis for EnerSys. Recent trading has been dominated by strong momentum, with a 19.4% 1 month share price return and 40.9% year to date share price return contributing to a 136.0% 1 year total shareholder return. This points to shifting...

Wondering if Cardinal Health at US$195.24 is still offering value after a strong multi year run? This article breaks down what the current price might be saying about the stock. The share price has eased recently, with a 2.3% decline over 7 days, a 7.9% decline over 30 days and a 5.1% decline year to date, even though the 1 year return stands at 32.0% and the 5 year return is 276.7%. Recent coverage around Cardinal Health has focused on its position in healthcare distribution and ongoing...

What recent returns suggest about C.H. Robinson Worldwide C.H. Robinson Worldwide (CHRW) has delivered mixed share price moves recently, with a 1 day return of 2.5% and a 7 day decline of 3.1%, while the past month shows a 5.2% gain. Over the past 3 months the stock shows a 9.1% decline, yet its 1 year total return of 98.9% and 5 year total return of 100.2% present a very different longer term picture for investors to weigh. See our latest analysis for C.H. Robinson Worldwide. At a share...